Retirement Systems of Alabama Purchases Shares of 825,842 Avantor, Inc. (NYSE:AVTR)

Retirement Systems of Alabama acquired a new position in Avantor, Inc. (NYSE:AVTR) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 825,842 shares of the company’s stock, valued at approximately $21,365,000. Retirement Systems of Alabama owned about 0.12% of Avantor as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Canada Pension Plan Investment Board grew its holdings in Avantor by 6.8% in the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock worth $486,059,000 after purchasing an additional 1,463,695 shares during the last quarter. State Street Corp boosted its position in shares of Avantor by 58.0% in the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after purchasing an additional 8,206,695 shares in the last quarter. Janus Henderson Group PLC grew its stake in Avantor by 18.2% during the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock worth $457,710,000 after buying an additional 2,719,615 shares during the last quarter. Geode Capital Management LLC increased its position in Avantor by 7.1% during the 3rd quarter. Geode Capital Management LLC now owns 11,150,788 shares of the company’s stock valued at $287,791,000 after buying an additional 739,667 shares in the last quarter. Finally, 1832 Asset Management L.P. raised its stake in Avantor by 1,634.9% in the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after buying an additional 8,038,451 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on AVTR shares. Robert W. Baird cut their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. UBS Group decreased their price target on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Barclays dropped their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. Royal Bank of Canada restated an “outperform” rating and issued a $34.00 target price on shares of Avantor in a research note on Thursday, September 26th. Finally, Wells Fargo & Company dropped their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, Avantor has a consensus rating of “Moderate Buy” and a consensus target price of $27.69.

Avantor Trading Down 0.9 %

Avantor stock opened at $22.33 on Friday. The firm has a market cap of $15.20 billion, a PE ratio of 48.54, a P/E/G ratio of 2.75 and a beta of 1.29. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00. The stock’s 50 day simple moving average is $22.47 and its two-hundred day simple moving average is $23.53. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.